Methylation-induced downregulation ofTFPI-2causesTMPRSS4overexpression and contributes to oncogenesis in a subset of non-small-cell lung carcinoma

Discovery of novel 2-hydroxydiarylamide derivatives as TMPRSS4 inhibitors

(2013) Sunghyun Kang et al.   BIOORGANIC & MEDICINAL CHEMISTRY LETTERS

Reduced expression of tissue factor pathway inhibitor-2 contributes to apoptosis and angiogenesis in cervical cancer

(2012) Qiao Zhang et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Overexpression of TMPRSS4 in non-small cell lung cancer is associated with poor prognosis in patients with squamous histology

(2011) L Larzabal et al.   BRITISH JOURNAL OF CANCER

Targeted Therapies for Lung Cancer

(2011) Jill E. Larsen et al.   CANCER JOURNAL

TFPI-2 methylation predicts poor prognosis in non-small cell lung cancer

(2011) Duoguang Wu et al.   LUNG CANCER

TMPRSS4 induces invasion and epithelial-mesenchymal transition through upregulation of integrin  5 and its signaling pathways

(2010) S. Kim et al.   CARCINOGENESIS

Transient RNA silencing of tissue factor pathway inhibitor-2 modulates lung cancer cell invasion

(2009) Sophie Iochmann et al.   CLINICAL & EXPERIMENTAL METASTASIS

Type II Transmembrane Serine Proteases

(2009) Thomas H. Bugge et al.   JOURNAL OF BIOLOGICAL CHEMISTRY

Methylation of CLDN6, FBN2, RBP1, RBP4, TFPI2, and TMEFF2 in esophageal squamous cell carcinoma

(2009) Tsunoda   ONCOLOGY REPORTS

Lung Cancer

(2008) Roy S. Herbst et al.   NEW ENGLAND JOURNAL OF MEDICINE